Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statement.

Journal

Nature reviews. Clinical oncology
ISSN: 1759-4782
Titre abrégé: Nat Rev Clin Oncol
Pays: England
ID NLM: 101500077

Informations de publication

Date de publication:
Nov 2020
Historique:
pubmed: 1 7 2020
medline: 1 7 2020
entrez: 1 7 2020
Statut: ppublish

Résumé

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiants

DOI: 10.1038/s41571-020-0412-0 PMID: 32601456 PMC: PMC7962565
pubmed: 32601456
doi: 10.1038/s41571-020-0412-0
pii: 10.1038/s41571-020-0412-0
pmc: PMC7962565
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

716

Subventions

Organisme : Cancer Research UK
ID : 27223
Pays : United Kingdom

Commentaires et corrections

Type : ErratumFor

Auteurs

Nora Pashayan (N)

Department of Applied Health Research, Institute of Epidemiology and Healthcare, University College London, London, UK.
ORCID: 0000-0003-0843-2468

Antonis C Antoniou (AC)

Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Urska Ivanus (U)

Epidemiology and Cancer Registry, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
ORCID: 0000-0002-7909-522X

Laura J Esserman (LJ)

Carol Franc Buck Breast Care Center, University of California, San Francisco, CA, USA.

Douglas F Easton (DF)

Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
ORCID: 0000-0003-2444-3247

David French (D)

Division of Psychology & Mental Health, School of Health Sciences, University of Manchester, Manchester, UK.
ORCID: 0000-0002-7663-7804

Gaby Sroczynski (G)

Department of Public Health, Health Services Research and Health Technology Assessment, Institute of Public Health, Medical Decision Making and Health Technology Assessment, UMIT-University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria.
Division of Health Technology Assessment, Oncotyrol - Center for Personalized Cancer Medicine, Innsbruck, Austria.

Per Hall (P)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Department of Oncology, Södersjukhuset, Stockholm, Sweden.

Jack Cuzick (J)

Wolfson Institute of Preventive Medicine, Barts and The London, Centre for Cancer Prevention, Queen Mary University of London, London, UK.

D Gareth Evans (DG)

Division of Evolution and Genomic Sciences, University of Manchester, Manchester, UK.

Jacques Simard (J)

Genomics Center, CHU de Québec - Université Laval Research Center, Québec, Canada.
ORCID: 0000-0001-6906-3390

Montserrat Garcia-Closas (M)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.

Rita Schmutzler (R)

Center of Family Breast and Ovarian Cancer, University Hospital Cologne, Cologne, Germany.

Odette Wegwarth (O)

Max Planck Institute for Human Development, Center for Adaptive Rationality, Harding Center for Risk Literacy, Berlin, Germany.

Paul Pharoah (P)

Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Department of Oncology, University of Cambridge, Cambridge, UK.
ORCID: 0000-0001-8494-732X

Sowmiya Moorthie (S)

PHG Foundation, Cambridge, UK.

Sandrine De Montgolfier (S)

IRIS Institute for Interdisciplinary Research on Social Issues, Paris, France.
ORCID: 0000-0002-4216-9379

Camille Baron (C)

Unicancer, Paris, France.

Zdenko Herceg (Z)

Epigenetic Group, International Agency for Research on Cancer (IARC), WHO, Lyon, France.
ORCID: 0000-0003-4109-3154

Clare Turnbull (C)

Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK.

Corinne Balleyguier (C)

Department Medical Imaging, Institut Gustave Roussy, Villejuif, France.

Paolo Giorgi Rossi (PG)

Epidemiology Unit, Azienda USL di Reggio Emilia - IRCCS, Reggio Emilia, Italy.

Jelle Wesseling (J)

Division of Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands.

David Ritchie (D)

Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
ORCID: 0000-0003-4816-113X

Marc Tischkowitz (M)

Department of Medical Genetics, National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK.

Mireille Broeders (M)

Department for Health Evidence, Radboud University Medical Center, Nijmegen, Netherlands.

Dan Reisel (D)

Department of Women's Cancer, Institute for Women's Health, University College London, London, UK.

Andres Metspalu (A)

The Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu, Estonia.
ORCID: 0000-0002-3718-796X

Thomas Callender (T)

Department of Applied Health Research, Institute of Epidemiology and Healthcare, University College London, London, UK.
ORCID: 0000-0001-8440-9433

Harry de Koning (H)

Department of Public Health, Erasmus MC, Rotterdam, Netherlands.
ORCID: 0000-0003-4682-3646

Peter Devilee (P)

Department of Human Genetics, Department of Pathology, Leiden University Medical Centre, Leiden, Netherlands.

Suzette Delaloge (S)

Breast Cancer Department, Gustave Roussy Institute, Paris, France.
ORCID: 0000-0003-2106-9165

Marjanka K Schmidt (MK)

Division of Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands.
ORCID: 0000-0002-2228-429X

Martin Widschwendter (M)

Department of Women's Cancer, Institute for Women's Health, University College London, London, UK. M.Widschwendter@ucl.ac.uk.
Universität Innsbruck, Innsbruck, Austria. M.Widschwendter@ucl.ac.uk.
European Translational Oncology Prevention and Screening (EUTOPS) Institute, Hall in Tirol, Austria. M.Widschwendter@ucl.ac.uk.
ORCID: 0000-0002-7778-8380

Classifications MeSH